Please login to the form below

Not currently logged in
Email:
Password:

Oxford PharmaGenesis launches its new HealthScience approach

Unveils integrated approach to engaging physicians, patients and policy-makers

Oxford PharmaGenesis HealthScienceUK-based consultancy Oxford PharmaGenesis has launched a new approach to developing robust evidence and communicating compelling insights to all stakeholders.

HealthScience integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.

Outlining the need for such an approach Dr Chris Winchester, managing director of Oxford PharmaGenesis, said: “The world already spends over a trillion dollars annually on medicines and surgical interventions, and new advances are being made all the time. 

“But we can't afford them all, so which ones should we choose? It is no longer enough to show that a new treatment is effective and safe. It must now also be cost-effective, and it must meet the expectations of patients and society.”

The company told PMLiVE that the HealthScience approach allows it to optimise the likelihood of healthcare technology assessment (HTA) success by understanding and integrating the perspectives of other key audiences.

Oxford PharmaGenesis has already trialed HealthScience in a number of therapy areas in the past year, including stroke, heart failure and schizophrenia, and said the concept had been positively received at meetings such as ISPOR and ISMPP.

Dr Richard White, commercial director at Oxford PharmaGenesis, said: “Our ideal is for HealthScience to be accepted as the standard approach to demonstrating the value of new therapies. 

“We have a powerful concept here. I would be delighted to see HealthScience departments being created in industry, and eventually in academia. We are seeing a revolution in healthcare, and it is exciting to be leading this initiative from Oxford, at the heart of British science and medicine.”

29th May 2014

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics